These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 405655)
21. [Individual chemotherapy of solid tumors]. Volm M; Mattern J Med Welt; 1976 Jun; 27(24):1171-6. PubMed ID: 781458 [No Abstract] [Full Text] [Related]
22. Rationale of combination chemotherapy based on preclinical experiments. Goldin A Cancer Chemother Rep 3; 1973 Mar; 4(2):189-98. PubMed ID: 4580857 [No Abstract] [Full Text] [Related]
23. Present status of cancer treatment in Korea. Kim JP; Hur DS Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1121-5. PubMed ID: 1514822 [No Abstract] [Full Text] [Related]
24. [The oncobiogram-- an indicator of chemotherapy in solid malignant human tumors]. Schönfelder M Zentralbl Chir; 1974 Sep; 99(38):1198-208. PubMed ID: 4454780 [No Abstract] [Full Text] [Related]
25. [Possibilities and indications of surgery for reduction of tumor volume or exeresis of metastases followed by chemotherapy and/or immunotherapy]. Mathe G; Garnier H; Kuss R; Binet JP; Le Brigand H; Genin J; Petit JY; Constans JP; Musset M; Schwarzenberg L; De Vassal F; Delgado M Chirurgie; 1976 May; 102(5):335-43. PubMed ID: 954531 [No Abstract] [Full Text] [Related]
26. [Current trends in the medical treatment of solid tumors]. González Barón M An R Acad Nac Med (Madr); 1992; 109(2):253-8. PubMed ID: 1463143 [No Abstract] [Full Text] [Related]
27. Recent developments in chemotherapy of malignancy. Bertino JR Laryngoscope; 1975 Mar; 85(3):491-8. PubMed ID: 1091794 [No Abstract] [Full Text] [Related]
28. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. de Pillis LG; Gu W; Radunskaya AE J Theor Biol; 2006 Feb; 238(4):841-62. PubMed ID: 16153659 [TBL] [Abstract][Full Text] [Related]
30. [Combination and complex treatment of malignant neoplasms]. Blokhin NN Vopr Onkol; 1973; 19(1):3-10. PubMed ID: 4701922 [No Abstract] [Full Text] [Related]
31. Clinical results with immunochemotherapy in 40 cases of advanced tumour. Narcisi M Panminerva Med; 1975; 17(5-6):208-10. PubMed ID: 1161322 [No Abstract] [Full Text] [Related]
32. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells? Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831 [TBL] [Abstract][Full Text] [Related]
33. High-dose chemotherapy with stem cell reinfusion and growth factor support for solid tumors. de Vries EG; de Graaf H; Boonstra A; van der Graaf WT; Mulder NH Stem Cells; 1995 Nov; 13(6):597-606. PubMed ID: 8590861 [TBL] [Abstract][Full Text] [Related]
34. [Value of combined treatment in non-metastatic solid tumors in the adult]. Rouëssé J; Floiras JL; Goupil A; Lasry S Rev Prat; 1988 Jun; 38(17):1073-80. PubMed ID: 3406646 [No Abstract] [Full Text] [Related]
35. [Foundations of the therapy of inoperable malignomas and hemoblastoses]. Stacher A Wien Med Wochenschr; 1976 Jan; 126(5):51-4. PubMed ID: 948909 [No Abstract] [Full Text] [Related]
37. Chemotherapy of solid tumours. World Health Organ Tech Rep Ser; 1977; (605):1-106. PubMed ID: 407727 [No Abstract] [Full Text] [Related]
38. [Combination chemotherapy and radiotherapy in the treatment of malignant tumors: indications and hazards]. Bartelink H; Somers R Ned Tijdschr Geneeskd; 1980 Apr; 124(15):564-8. PubMed ID: 7374818 [No Abstract] [Full Text] [Related]
39. [Polychemotherapy of solid tumors]. Almici C; Inzoli MR; Lazzaroni G; D'Adda P; Zambruni A G Clin Med; 1974 Apr; 55(4):304-12. PubMed ID: 4452440 [No Abstract] [Full Text] [Related]
40. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer. Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]